BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 24001739)

  • 1. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.
    Al-Saaidi R; Rasmussen TB; Palmfeldt J; Nissen PH; Beqqali A; Hansen J; Pinto YM; Boesen T; Mogensen J; Bross P
    Exp Cell Res; 2013 Nov; 319(19):3010-9. PubMed ID: 24001739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
    Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
    Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations.
    Arimura T; Onoue K; Takahashi-Tanaka Y; Ishikawa T; Kuwahara M; Setou M; Shigenobu S; Yamaguchi K; Bertrand AT; Machida N; Takayama K; Fukusato M; Tanaka R; Somekawa S; Nakano T; Yamane Y; Kuba K; Imai Y; Saito Y; Bonne G; Kimura A
    Cardiovasc Res; 2013 Aug; 99(3):382-94. PubMed ID: 23631840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
    Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
    J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incomplete nonsense-mediated decay of mutant lamin A/C mRNA provokes dilated cardiomyopathy and ventricular tachycardia.
    Geiger SK; Bär H; Ehlermann P; Wälde S; Rutschow D; Zeller R; Ivandic BT; Zentgraf H; Katus HA; Herrmann H; Weichenhan D
    J Mol Med (Berl); 2008 Mar; 86(3):281-9. PubMed ID: 17987279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy.
    Taylor MR; Slavov D; Gajewski A; Vlcek S; Ku L; Fain PR; Carniel E; Di Lenarda A; Sinagra G; Boucek MM; Cavanaugh J; Graw SL; Ruegg P; Feiger J; Zhu X; Ferguson DA; Bristow MR; Gotzmann J; Foisner R; Mestroni L;
    Hum Mutat; 2005 Dec; 26(6):566-74. PubMed ID: 16247757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative expression of the mutated lamin A/C gene in patients with cardiolaminopathy.
    Narula N; Favalli V; Tarantino P; Grasso M; Pilotto A; Bellazzi R; Serio A; Gambarin FI; Charron P; Meder B; Pinto Y; Elliott PM; Mogensen J; Bolognesi M; Bollati M; Arbustini E
    J Am Coll Cardiol; 2012 Nov; 60(19):1916-20. PubMed ID: 23062543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.
    Sylvius N; Bilinska ZT; Veinot JP; Fidzianska A; Bolongo PM; Poon S; McKeown P; Davies RA; Chan KL; Tang AS; Dyack S; Grzybowski J; Ruzyllo W; McBride H; Tesson F
    J Med Genet; 2005 Aug; 42(8):639-47. PubMed ID: 16061563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy.
    Chandar S; Yeo LS; Leimena C; Tan JC; Xiao XH; Nikolova-Krstevski V; Yasuoka Y; Gardiner-Garden M; Wu J; Kesteven S; Karlsdotter L; Natarajan S; Carlton A; Rainer S; Feneley MP; Fatkin D
    Circ Res; 2010 Feb; 106(3):573-82. PubMed ID: 20019332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice.
    Nikolova V; Leimena C; McMahon AC; Tan JC; Chandar S; Jogia D; Kesteven SH; Michalicek J; Otway R; Verheyen F; Rainer S; Stewart CL; Martin D; Feneley MP; Fatkin D
    J Clin Invest; 2004 Feb; 113(3):357-69. PubMed ID: 14755333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of fibroblasts in a family with LMNA-related cardiomyopathy reveals molecular pathways implicated in disease pathogenesis.
    Widyastuti HP; Norden-Krichmar TM; Grosberg A; Zaragoza MV
    BMC Med Genet; 2020 Jul; 21(1):152. PubMed ID: 32698886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy.
    Perrot A; Hussein S; Ruppert V; Schmidt HH; Wehnert MS; Duong NT; Posch MG; Panek A; Dietz R; Kindermann I; Böhm M; Michalewska-Wludarczyk A; Richter A; Maisch B; Pankuweit S; Ozcelik C
    Basic Res Cardiol; 2009 Jan; 104(1):90-9. PubMed ID: 18795223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
    Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
    Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.
    Fatkin D; MacRae C; Sasaki T; Wolff MR; Porcu M; Frenneaux M; Atherton J; Vidaillet HJ; Spudich S; De Girolami U; Seidman JG; Seidman C; Muntoni F; Müehle G; Johnson W; McDonough B
    N Engl J Med; 1999 Dec; 341(23):1715-24. PubMed ID: 10580070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice.
    Mounkes LC; Kozlov SV; Rottman JN; Stewart CL
    Hum Mol Genet; 2005 Aug; 14(15):2167-80. PubMed ID: 15972724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
    van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
    Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling Treatment Response for Lamin A/C Related Dilated Cardiomyopathy in Human Induced Pluripotent Stem Cells.
    Lee YK; Lau YM; Cai ZJ; Lai WH; Wong LY; Tse HF; Ng KM; Siu CW
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28754655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel mutations in LMNA associated with familial forms of dilated cardiomyopathy.
    Stallmeyer B; Koopmann M; Schulze-Bahr E
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):543-9. PubMed ID: 22224630
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Kato K; Ohno S; Sonoda K; Fukuyama M; Makiyama T; Ozawa T; Horie M
    Circ Genom Precis Med; 2020 Oct; 13(5):435-443. PubMed ID: 32818388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. R25G mutation in exon 1 of LMNA gene is associated with dilated cardiomyopathy and limb-girdle muscular dystrophy 1B.
    Yuan WL; Huang CY; Wang JF; Xie SL; Nie RQ; Liu YM; Liu PM; Zhou SX; Chen SQ; Huang WJ
    Chin Med J (Engl); 2009 Dec; 122(23):2840-5. PubMed ID: 20092787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.